📊 CSUI Key Takeaways
Investment Thesis
Cannabis Suisse Corp demonstrates severe financial distress with negative stockholders' equity of -$1.8M, zero revenue, and persistent operating losses. The company is technically insolvent with liabilities ($2.3M) far exceeding assets ($510K), indicating imminent bankruptcy risk without immediate capital restructuring.
CSUI Strengths
- Minimal cash burn rate relative to asset base provides short-term operational runway
- Real estate sector classification may provide underlying asset value not reflected in reported metrics
- Low absolute liability amounts suggest manageable debt obligations if operational turnaround occurs
CSUI Risks
- Negative stockholders' equity of -$1.8M indicates technical insolvency and substantial shareholder dilution risk
- Zero revenue with -$159.5K operating losses demonstrates complete lack of business operations or commercial viability
- Critically low liquidity with 0.19x current ratio and only $2.6K cash against $2.3M liabilities creates immediate solvency crisis
- Long-term debt of $610.7K against zero revenue makes debt service mathematically impossible without external capital injection
- Negative operating cash flow of -$32.2K with zero revenue indicates business cannot sustain itself operationally
Key Metrics to Watch
- Stockholders' equity trajectory and any debt restructuring announcements
- Revenue generation or business combination announcements indicating operational restart
- Cash position changes and any capital raises or financing activities through Form 4/8-K filings
CSUI Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CSUI Profitability Ratios
CSUI vs Default Sector
How CANNABIS SUISSE CORP. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CSUI Balance Sheet & Liquidity
CSUI 5-Year Financial Trend
5-Year Trend Summary: CANNABIS SUISSE CORP.'s revenue has declined by 88% over the 5-year period, indicating business contraction. The most recent EPS of $-0.03 indicates the company is currently unprofitable.
CSUI Growth Metrics (YoY)
CSUI Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | N/A | $5.1K | $0.00 |
| Q1 2026 | N/A | $13.9K | $0.00 |
| Q3 2025 | $7.5K | $29.5K | $0.00 |
| Q2 2025 | $7.5K | $5.1K | $0.00 |
| Q1 2025 | $7.5K | -$64.8K | N/A |
| Q3 2024 | $2.5K | -$68.0K | N/A |
| Q2 2024 | N/A | -$30.1K | N/A |
| Q1 2024 | N/A | -$64.8K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CSUI Capital Allocation
CSUI SEC Filings
Access official SEC EDGAR filings for CANNABIS SUISSE CORP. (CIK: 0001680132)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CSUI
What is the AI rating for CSUI?
CANNABIS SUISSE CORP. (CSUI) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CSUI's key strengths?
Minimal cash burn rate relative to asset base provides short-term operational runway. Real estate sector classification may provide underlying asset value not reflected in reported metrics.
What are the risks of investing in CSUI?
Negative stockholders' equity of -$1.8M indicates technical insolvency and substantial shareholder dilution risk. Zero revenue with -$159.5K operating losses demonstrates complete lack of business operations or commercial viability.
What is CSUI's revenue and growth?
CANNABIS SUISSE CORP. reported revenue of $0.0.
Does CSUI pay dividends?
CANNABIS SUISSE CORP. does not currently pay dividends.
Where can I find CSUI SEC filings?
Official SEC filings for CANNABIS SUISSE CORP. (CIK: 0001680132) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CSUI's EPS?
CANNABIS SUISSE CORP. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.